Loading data
MYGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 824.5 m USD | 837.6 m USD | 753.2 m USD | 678.4 m USD | 690.6 m USD |
| Cost of revenue | 247.9 m USD | 252.2 m USD | 236.2 m USD | 202 m USD | — |
| Gross profit | 576.6 m USD | 585.4 m USD | 517 m USD | 476.4 m USD | — |
| Research and development expense | 106.8 m USD | 113.4 m USD | 88.7 m USD | 85.4 m USD | 81.9 m USD |
| Selling, general and administrative expense | — | — | 572.9 m USD | 514.7 m USD | 537.8 m USD |
| Operating profit | -387.2 m USD | -123.5 m USD | -257.4 m USD | -140.6 m USD | -190.5 m USD |
| Interest expense | — | — | 2.9 m USD | 3.2 m USD | 6.6 m USD |
| Profit before tax | -395.1 m USD | -123.5 m USD | -262.2 m USD | -140.6 m USD | -57.1 m USD |
| Income tax expense | -29.2 m USD | 3.8 m USD | 1.1 m USD | -28.6 m USD | -29.9 m USD |
| Net income (reported basis) | -366 m USD | -127 m USD | -263 m USD | -112 m USD | -27 m USD |
| Basic earnings per share | -3.95 USD/share | -1.41 USD/share | -3.18 USD/share | -1.39 USD/share | -0.35 USD/share |
| Diluted earnings per share | -3.95 USD/share | -1.41 USD/share | -3.18 USD/share | -1.39 USD/share | -0.35 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.